Every government allocates a substantial proportion of its total health budget to medicines. This
proportion tends to be greatest in developing countries, where it may exceed 40%.
Without assurance that these medicines are relevant to priority health needs and that they meet
acceptable standards of quality, safety and efficacy, any health service is evidently compromised. In
developing countries considerable administrative and technical effort is directed to ensuring that
patients receive effective medicines of good quality. It is crucial to the objective of health for all that a
reliable system of medicines control be brought within the reach of every country.
Both for manufacturers and at national level, good manufacturing practices (GMP) are an important
part of a comprehensive system of quality assurance.
Continue at: https://repository.publisso.de/resource/frl:5111614-1/data
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link